TherapeuticsMD, Inc. reported the outcomes of its 2025 Annual Meeting on December 15, 2025, where stockholders elected directors, approved executive compensation, ratified their auditor, and increased authorized shares to 640 million. This filing holds significant importance for investors as key governance changes were approved.